Controlled registryRecord class / Research peptides HGH Fragment 176-191 RECORD HGH-FRAGMENT-176-191 / CLASS RESEARCH PEPTIDES / IDENTIFIERS 6. AcuPep uses this page to preserve the product-to-SKU link before evidence requirements enter the inquiry queue.
C-terminal fragment of human growth hormone (176–191)
Control sequence Identifier lock precedes evidence applicability Resolve product, content and SKU; then declare quantity, destination, timing and acceptance questions.
Identifier matrix
Controlled content / SKU pairs 1 mg FRAG1
2 mg FRAG2
5 mg FRAG5
10 mg FRAG10
12 mg FRAG12
15 mg FRAG15
STATUS: catalog reference. Availability, presentation and commercial constraints require a returned quotation.
Evidence gate Declare the required record type and acceptance context. Evidence is linked only when it applies to the requested configuration or released lot.
Storage constraint Store and ship according to the released-lot COA and validated data for the exact sequence, disulfide state, salt/counterion, formulation, solvent, concentration and container. A generic 2–8 °C or -20 °C rule does not establish solution life, freeze-thaw allowance or long-term stability for the supplied form.
Technical intake / linked record Reference HGH Fragment 176-191 in a controlled brief Include SKU, content, quantity, destination and evidence requirements. AcuPep will preserve these identifiers in the inquiry record.
Was this page useful for your review? Yes Not yet